0,1,2,3,4,5,6
Table 6.1.6: Randomised trials of dose escalation in localised PCa,,,,,,
Trial,n,PCa condition,"Radiotherapy 
Dose","Follow-up 
(median)",Outcome,Results
"MD Anderson 
study 2011 
[652]",301,"T1-T3, N0, M0, 
PSA < 10 ng/mL
PSA 10-20 ng/mL
PSA > 20 ng/mL",70 vs.78 Gy,15 yr.,"DM, DSM, 
FFF","All patients:
18.9% FFF at 70 Gy
12% FFF at 78 Gy
(p = 0.042)
3.4% DM at 70 Gy
1.1% DM at 78 Gy
(p = 0.018)
6.2% DSM at 70 Gy
3.2% DSM at 78 Gy
(p = 0.043)
No difference in OS
(p > 0.05)"
"PROG 95-09 
2010 [646]",393,"T1b-T2b  
PSA < 15 ng/mL
75% low-risk pts.
Low-risk: T1-2a, 
PSA < 10 mg/mL, 
GS < 6
Interm-risk: PSA 
10-15 ng/mL or 
GS 7 or T2b
High-risk: GS 
8-10","70.2 vs.79.2 Gy 
including 
proton boost 
19.8 vs. 28.8 Gy",8.9 yr.,"10-yr. 
ASTRO BCF","All patients: 
32% BF at 70.2 Gy 
17% BF at 79.2 Gy 
(p < 0.0001) 
Low-risk patients: 
28% BF at 70.2 Gy 
7% BF at 79.2 Gy 
(p < 0.0001)"
"MRC RT01 
2014 [651]",843,"T1b-T3a, N0, M0 
PSA < 50 ng/mL 
neoadjuvant HT",64 vs. 74 Gy,10 yr.,"BFS, OS","43% BFS at 64 Gy 
55% BFS at 74 Gy 
(p = 0.0003)  
71% OS both groups 
(p = 0.96)"
"Dutch 
randomised 
phase III trial 
2014 [650]",664,"T1b-T4 143 pts. 
with (neo) 
adjuvant HT",68 vs. 78 Gy,110 mo.,"Freedom 
biochemical 
(Phoenix) 
and/or clinical 
failure at 
10 yr.","43% FFF at 68 Gy 
49% FFF at 78 Gy 
(p = 0.045)"
"GETUG 06 
2011 [649]",306,"T1b-T3a, N0, M0 
PSA < 50 ng/mL",70 vs. 80 Gy,61 mo.,BCF (ASTRO),"39% BF at 70 Gy 
28% BF at 80 Gy"
"RTOG 0126 
2018 [645]","1,532","T1b-T2b 
ISUP grade 1 
+ PSA 10-20 
ng/mL or ISUP 
grade 2/3 + 
PSA < 15 ng/mL",70.2 vs. 79.2 Gy,100 mo.,"OS, DM, BCF 
(ASTRO)","75% OS at 70.2 Gy 
76% OS at 79.2 Gy 
6% DM at 70.2 Gy 
4% DM at 79.2 Gy 
(p = 0.05) 
47% BCF at 70.2 Gy 
31% BCF at 79.2 Gy 
(p < 0.001; 
Phoenix, p < 0.001)"
"FLAME Trial
[654, 655]",571,"EAU risk 
classification: 
Intermediate risk 
(15%)
High risk (84%)","77 Gy (35 fx. 
2.2 Gy) vs.  
77 Gy (35 Fx.) 
+ focal boost 
(up to 18 Gy) 
ADT (65% both 
arms â€“ duration 
unknown)","72 mo. 
(median)","BFS (5 yr.) 
DSM (5 yr.)","BFS: 
92% at 77 Gy + boost 
85% at 77 Gy 
(p < 0.001, HR: 0.45)  
DSM: p = 0.49
Focal boost in favour 
of: Local control  
(HR: 0.33)  
Distant MFS  
(HR: 0.58)"
